List of Excipients in API olanzapine and fuoxetine
✉ Email this page to a colleague
Excipients in ANDA-approved (generic) drugs containing olanzapine and fuoxetine
Detailed excipient profiles for olanzapine and fuoxetine
Excipient focus: ALCOHOL
olanzapine and fuoxetine drug variants containing ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| Endo USA Inc | olanzapine and fuoxetine | 49884-277 |
| >Company | >Ingredient | >NDC |
olanzapine and fuoxetine drug variants not containing ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: D&C YELLOW NO. 10
olanzapine and fuoxetine drug variants containing D&C YELLOW NO. 10
| Company | Ingredient | NDC |
|---|---|---|
| Endo USA Inc | olanzapine and fuoxetine | 49884-277 |
| >Company | >Ingredient | >NDC |
olanzapine and fuoxetine drug variants not containing D&C YELLOW NO. 10
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: FD&C BLUE NO. 1
olanzapine and fuoxetine drug variants containing FD&C BLUE NO. 1
| Company | Ingredient | NDC |
|---|---|---|
| Endo USA Inc | olanzapine and fuoxetine | 49884-277 |
| >Company | >Ingredient | >NDC |
olanzapine and fuoxetine drug variants not containing FD&C BLUE NO. 1
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: FD&C BLUE NO. 2
olanzapine and fuoxetine drug variants containing FD&C BLUE NO. 2
| Company | Ingredient | NDC |
|---|---|---|
| Endo USA Inc | olanzapine and fuoxetine | 49884-277 |
| >Company | >Ingredient | >NDC |
olanzapine and fuoxetine drug variants not containing FD&C BLUE NO. 2
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: FD&C RED NO. 40
olanzapine and fuoxetine drug variants containing FD&C RED NO. 40
| Company | Ingredient | NDC |
|---|---|---|
| Endo USA Inc | olanzapine and fuoxetine | 49884-277 |
| >Company | >Ingredient | >NDC |
olanzapine and fuoxetine drug variants not containing FD&C RED NO. 40
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: FERRIC OXIDE RED
olanzapine and fuoxetine drug variants containing FERRIC OXIDE RED
| Company | Ingredient | NDC |
|---|---|---|
| Endo USA Inc | olanzapine and fuoxetine | 49884-277 |
| >Company | >Ingredient | >NDC |
olanzapine and fuoxetine drug variants not containing FERRIC OXIDE RED
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: FERRIC OXIDE YELLOW
olanzapine and fuoxetine drug variants containing FERRIC OXIDE YELLOW
| Company | Ingredient | NDC |
|---|---|---|
| Endo USA Inc | olanzapine and fuoxetine | 49884-277 |
| >Company | >Ingredient | >NDC |
olanzapine and fuoxetine drug variants not containing FERRIC OXIDE YELLOW
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: FERROSOFERRIC OXIDE
olanzapine and fuoxetine drug variants containing FERROSOFERRIC OXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Endo USA Inc | olanzapine and fuoxetine | 49884-277 |
| >Company | >Ingredient | >NDC |
olanzapine and fuoxetine drug variants not containing FERROSOFERRIC OXIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: GELATIN
olanzapine and fuoxetine drug variants containing GELATIN
| Company | Ingredient | NDC |
|---|---|---|
| Endo USA Inc | olanzapine and fuoxetine | 49884-277 |
| >Company | >Ingredient | >NDC |
olanzapine and fuoxetine drug variants not containing GELATIN
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: MAGNESIUM STEARATE
olanzapine and fuoxetine drug variants containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| Endo USA Inc | olanzapine and fuoxetine | 49884-277 |
| >Company | >Ingredient | >NDC |
olanzapine and fuoxetine drug variants not containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: METHYL ALCOHOL
olanzapine and fuoxetine drug variants containing METHYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| Endo USA Inc | olanzapine and fuoxetine | 49884-277 |
| >Company | >Ingredient | >NDC |
olanzapine and fuoxetine drug variants not containing METHYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: PROPYLENE GLYCOL
olanzapine and fuoxetine drug variants containing PROPYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| Endo USA Inc | olanzapine and fuoxetine | 49884-277 |
| >Company | >Ingredient | >NDC |
olanzapine and fuoxetine drug variants not containing PROPYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: SHELLAC
olanzapine and fuoxetine drug variants containing SHELLAC
| Company | Ingredient | NDC |
|---|---|---|
| Endo USA Inc | olanzapine and fuoxetine | 49884-277 |
| >Company | >Ingredient | >NDC |
olanzapine and fuoxetine drug variants not containing SHELLAC
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: STARCH, CORN
olanzapine and fuoxetine drug variants containing STARCH, CORN
| Company | Ingredient | NDC |
|---|---|---|
| Endo USA Inc | olanzapine and fuoxetine | 49884-277 |
| >Company | >Ingredient | >NDC |
olanzapine and fuoxetine drug variants not containing STARCH, CORN
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: TITANIUM DIOXIDE
olanzapine and fuoxetine drug variants containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Endo USA Inc | olanzapine and fuoxetine | 49884-277 |
| >Company | >Ingredient | >NDC |
olanzapine and fuoxetine drug variants not containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2025 - 2026
NCE-1 Patent Challenge Dates 2025 - 2026
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2025, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch